Our engineers set up and run your first chatbot / LLM security scan. Get in touch

LLM risk does not fit the manual pentest cadence.

Three failure modes show up in every LLM incident review we read. None of them is visible in a SIEM or an EDR feed. Penaxtra closes all three.

73%
LLM apps

susceptible to prompt-injection in our 2026 sample.

11min
Median dwell time

from first poisoned read to first tool exfil.

0
SIEM/EDR coverage

prompt + tool args never reach perimeter sensors.

Three gaps every LLM team hits.

The same failure modes show up across banking, healthcare and public sector incident reviews.

LLM01 · Prompt Injection

Untrusted text becomes instructions.

An agent reads a PDF, a webpage, or a Slack message and silently obeys it. Your WAF cannot see this; the bytes look identical to a normal completion call.

LLM06 · Sensitive Disclosure

Tool calls exfiltrate credentials.

A function-calling agent has a database connection, a payment-processor key, and an HTTP tool. One crafted prompt and your secrets leave the network, labelled as a normal API request.

Shadow AI

Nobody owns the MCP server list.

Engineers spin up MCP servers in days. Six months later, security finds out a customer-facing agent has been calling an unreviewed third-party tool the whole time.

Regulated mid-market shipping LLM features.

Banking + fintech

Customer-facing assistants and internal copilots under EU AI Act scrutiny. Continuous prompt-injection + data-exfiltration checks.

Healthcare

Clinical decision support and patient-facing chat under GDPR and national health authority rules. PII handling and overreliance checks baked in.

Insurance

Underwriting copilots and claims triage. Fairness + leakage + reasoning robustness, mapped to NIST AI 600-1 Manage controls.

Public-sector contractors

Tender-driven obligations around ISO 42001, EU AI Act high-risk applicability, and traceable evidence. Penaxtra ships the evidence directly.

See how Penaxtra closes the gap.

Discovery, runtime gating, adversarial scans, and audit evidence on one platform.

Tour the product